x
Filter:
Filters applied
- Oncology
- Abel, E JasonRemove Abel, E Jason filter
- 2018 - 2023Remove 2018 - 2023 filter
Author
- Dreyfuss, Leo D2
- Master, Viraj A2
- Wells, Shane A2
- Allen, Glenn O1
- Bagrodia, Aditya1
- Best, Sara L1
- Boorjian, Stephen A1
- Borregales, Leonardo D1
- Chen, Gong1
- Hedican, Sean P1
- Hinshaw, J Louis1
- Hutchinson, Ryan1
- Karam, Jose A1
- Krabbe, Laura-Maria1
- Lee, Fred T Jr1
- Leibovich, Bradley C1
- Lubner, Meghan G1
- Margulis, Vitaly1
- Masterson, Timothy1
- Matin, Surena F1
- Meissner, Matthew1
- Merrill, Suzanne B1
- Nakada, Stephen Y1
- Patil, Dattatraya1
Oncology
3 Results
- Oncology
Patterns of Initial Metastatic Recurrence After Surgery for High-Risk Nonmetastatic Renal Cell Carcinoma
UrologyVol. 146p152–157Published online: August 8, 2020- Leo D. Dreyfuss
- Viraj A. Master
- Jay D. Raman
- Philippe E. Spiess
- Shane A. Wells
- Suzanne B. Merrill
- and others
Cited in Scopus: 0To evaluate postoperative recurrence patterns for high-risk nonmetastatic renal cell carcinoma (RCC) and to identify prognostic factors associated with site-specific metastatic recurrence using a multi-institutional contemporary cohort. - Oncology
Development of a Risk-stratified Approach for Follow-up Imaging After Percutaneous Thermal Ablation of Sporadic Stage One Renal Cell Carcinoma
UrologyVol. 134p148–153Published online: August 26, 2019- Leo D. Dreyfuss
- Shane A. Wells
- Sara L. Best
- Sean P. Hedican
- Timothy J. Ziemlewicz
- Meghan G. Lubner
- and others
Cited in Scopus: 6To analyze risk factors and patterns of RCC recurrence following percutaneous ablation for stage 1 tumors and develop risk-stratified follow-up imaging protocols. - Oncology
The Adverse Survival Implications of Bland Thrombus in Renal Cell Carcinoma With Venous Tumor Thrombus
UrologyVol. 115p119–124Published online: February 27, 2018- Ryan Hutchinson
- Charles Rew
- Gong Chen
- Solomon Woldu
- Laura-Maria Krabbe
- Matthew Meissner
- and others
Cited in Scopus: 13To characterize the presence of bland (nontumor) thrombus in advanced renal cell carcinoma and assess the impact of this finding on cancer-specific survival.